AI assistant
SMS Pharmaceuticals Ltd Major Shareholding Notification 2019
62302_rns_2019-09-18_f920ad46-fe7a-40b5-8291-4353adcf3ba5.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Registered & Corporate Office: Plot No. 72, H. No. 8-2-334/3 & 4, Road No.5, Opp. SBI Executive Enclave, Banjara Hills, Hyderabad - 500 034, Telangana , INDIA. Tel: +91-40-25259999, Fax : +91-40-2525 9889 CIN : L24239TG1987PLC008066 Email: [email protected], www.smspharma.com
Date: 18th September, 2019
To, The Manager, Corporate Filings Department, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400 001
The Manager, Listing Compliance Department, National Stock Exchange of India Ltd. Exchange Plaza, Plot no. C/ 1, G Block, Bandra-Kurla Complex, Bandra (EJ, Mumbai - 400 051.
Security Code: 532815
Symbol: SMSPHARMA
Dear Sir/Madam,
Sub: Revised filling of Reporting under Regulation 29( 1)) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 read with SEBI (Prohibition of Insider Trading) Regulations, 2015 (Regulation 7(2) read with Regulation 6(2))
With reference to the above please find the enclosed revised disclosure under Regulation 29(1) of SEBI (Substantial acquisition of shares and takeover) Regulation 2011 and Regulation 7(2) of SEBI (Prohibition of insider trading) Regulations 2015, which have been wrongly disclosed under the different forma t on 17th September 201 9, u n der regula tion s 30(1) and 30(2 ) of the SEBI (Substantial acquisition of shares and takeover) Regulations 2011 and regulation 7(2) of SEBI (Prohibition of insider trading) Regulations 2015 and requesting to kindly update the revised disclosures for the shares by way of gift by Mrs. Sukumari Koneru to one of her nearest relative to Mr, Vamsi Krishna Potluri who is the recipient of the gifted shares,
This is for your information and Records.
Your faithfully For SMS Pharmaceuticals Limited
V.S.Venkatish Company Secretary
Dated: 18.09.2019
To
Company Secretary SMS Pharmaceuticals Limited Plot.No. 72, H.No. 8-2-334/3&4, Road No.5 Opp. SBI Executive Enclave, Banjara Hills, Hyderabad.
Dear Sir,
Sub: Revised filing under Regulation 29(1) of SEBI (Substantial Acquisitions and takeovers) Regulation's, read with SEBI (Prohibition of Insider Trading) Regulations, 2015 and (Regulation 7(2) read with Regulation 6(2)) of Securities and Exchange Board of India
With reference to the above subject, please fmd the revised fillings under Regulations 29(1) of SEBI (Substantial Acquisitions and takeovers) Regulations read with SEBI (Prohibition of Insider Trading Regulations, 2015, which have been wrongly disclosed on 16th September, 2019 under the different format of the Regulation 30(1) and 30(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulation's and Regulation 7(2) read with Regulation 6(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 in respect of the transfer of Shares to her immediate relative Mr. Vamsi Krishna Potluri on 11th September, 2019.
This is for your information and records.
k~u~~'
Sukumari Koneru
Format for disclosures under Regulation 29(1) of SEBl (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
~art - A - Details of the Acquisition
| Name of the Target Company (TC) | SMS Pharmaceuticals Limited | ||||||
|---|---|---|---|---|---|---|---|
| Name(s) of the acquirer and Persons Acting in | Sukumari Koneru | ||||||
| Concert (PAC) with the acquirer | |||||||
| WhethertheacqUlrerbelongsto | NO | ||||||
| Promoter/Promoter group | |||||||
| Name(s) of the Stock Exchange(s) where the | BSE&NSE | ||||||
| shares of TC are Listed | |||||||
| Details of the acquisition as follows | Number | % w.r.t. total | % w.r.t. | ||||
| share/voting | total diluted | ||||||
| capital | share/voting | ||||||
| wherever | capital of | ||||||
| applicable | the TC (*) | ||||||
| Before the acquisitionl under consideration, | 40,000 | 0.05 | |||||
| holding of acquirer along with the P ACs of: | |||||||
| a) | Shares carrying voting rights | ||||||
| b) | of encumbranceSharesinthenature | ||||||
| Voting rights (VR)otherwise thanby | |||||||
| equity shares | |||||||
| c) | Warrants/convertible securities/any other | ||||||
| instrument that entitles the acquirer to | |||||||
| receive shares carrying voting rights in the | |||||||
| TC (specify holding in each category) | |||||||
| d) Total (a+b+c) | 40,000 | 0.05 | |||||
| Details of acquisition/sale | 20,000 | 0.02 | |||||
| a) | Shares carrying voting rights acquired | ||||||
| b) | VRs acquired otherwise than by equity | ||||||
| shares | |||||||
| c) | Warrants/conveltible securities/any other | ||||||
| instrument that entitles the acquirer to | |||||||
| receive shares carrying voting rights in the | |||||||
| TC (specify holding ineach category) | |||||||
| acquired/sold | |||||||
| d) Total (a+b+c) | 20,000 | 0.02 | |||||
| After the acquisition/sale, holding of: | 20,000 | 0.02 | |||||
| a) | Shares carrying voting rights | ||||||
| b) | VRs otherwise than by equity shares | ||||||
| c) | Warrants!convertible securities/any other | ||||||
| instrument that entitles the acquirer to | |||||||
| recei ve shares carrying voting rights in the | |||||||
| TC (specify holding in each category) | |||||||
| L---. | __after acquisition•• u. __~ __ ._~" ••• | -- ---------~~----.- |
| r-~~~~~--~-------------------r~~~----'-~~------'--------------Total (a+b+c)d) | I 0.02I20,000 |
|---|---|
| J.jode of acquisition/sale (e.g. open market / | Gifted to her immediate relative |
| ()ff-market/publicissue/rightsissue | |
| 1referential allotment / inter-se transfer etc.) | |
| Date of acquisition / sale of shares / VR or date | 18.09.2019 |
| ()f receipt of intimation of allotment of shares, | |
| Vihichever is applicable | |
| Equity share capital/total voting capital of the | 8,46,52,030 Equity Shares of Re 1/-(Rupee |
| IC before the said acquisition/sale | one each) aggregating to Rs. 8,46,52,030 |
| Equity share capital! total voting capital of the | 8,46,52,030 Equity Shares of Re 1/-(Rupee |
| IC after the said acquisition/sale | one each) aggregating to Rs. 8,46,52,030 |
| lotal diluted share/voting capital of the TC | NA |
| after the said acquisition/sale |
k~' "' " . ""<"r61J~ . , U ~" ..
Sukumari Koneru
Place: Hyderabad Date: 18.09.2019
FORM C
Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 $\sqrt{\text{Regulation 7 (2) read with Regulation 6(2)}}$
Name of the company: SMS Pharmaceuticals Limited
ISIN of the company: INE812G01025
Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).
| Name,PAN No.,CIN/DIN,& addressofPromoter/Employee /Director | Categoryof Person(Promoters$/$ KMP $/$Directors/immediaterelatives/others | Securities heldprior toacquisition/ | disposal/Release | Securities | acquired/Disposed/release/ | release | Securities held postacquisition/disposal/ | Date ofallotmentadvice/acquisition ofshares/sale of sharesspecify-release ofPledge shares ( | Date$\sigma$ fintimation tocompany | Mode ofAcquisition/Disposal(marketpurchase/publicrights/ | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| withcontactnos. | etc. | Typeofsecurity(Foreg. -SharesWarrants,ConvertibleDebentures etc.) | No.and %$_{\rm ot}$shareholding | Type ofsecurity(For eg. $-$Shares,Warrants,ConvertibleDebenturesetc.) | No. | Value | TransactionType(Buy/Sale/Pledge /Revoke/Invoke)release | Type ofsecurity(For eg.Shares,WarrantsConvertibleDebentures etc.) | No. and %ofshareholding | From | To | preferentialoffer / offmarket/Inter-setransferetc | |
| $\mathbf{1}$ | $\overline{2}$ | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| SukumariKoneruPAN:AIJPK3578LH.No: Plot No:21, SukumariSadan, AP DairyOfficers Colony,Vijayawada,Andhra Pradesh500008 | ImmediateRelative | Equitуshares | 40,000/-0.05 | EquityShares | 20,000 | $0$ /- (By wayof gift) | Gifted toherrelative | EquityShares | $20,000/-$0.02% | 11.09.2019by way ofGift | 11.09.2019 | 16.09.2019 | Gifted toherimmediate relative |
Details of trading in derivatives of the company by Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)
| Trading in derivatives (Specify type of contract, Futures or Options etc) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Type of | Contract | Buy | Sell | |||||
| Contract | Specifications | Notional Value | Number of units(contracts * lotsize) | Notional Value | Number of units(contracts * lotsize) | |||
| 15 | 16 | 17 | 18 | 19 | 20 | 21 | ||
| Na |
kUu..n~·
Signature: Sukumari Koneru
Date: 18.09.2019 Place: Hyderabad Dated: 18.09.2019
To
Company Secretary SMS Pharmaceuticals Limited Plot.No. 72, H.No. 8-2-334/3&4, Road No.5 Opp. SBI Executive Enclave, Banjara Hills, Hyderabad.
Dear Sir,
Sub: Revised filing under Regulation 29(1) of SEBI (Substantial Acquisitions and takeovers) Regulation's, read with SEBI (Prohibition of Insider Trading) Regulations, 2015 and (Regulation 7(2) read with Regulation 6(2)) of Securities and Exchange Board of India.
With reference to the above subject, please find the revised fillings under Regulations 29(1) of SEBI (Substantial Acquisitions and takeovers) Regulations read with SEBI (Prohibition of Insider Trading Regulations, 2015, which have been wrongly disclosed on 16th September, 2019 under the different format under the Regulation 30(1) and 30(2) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulation's and Regulation 7(2) read with Regulation 6(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 in respect of the transfer of Shares received from his immediate relative Mrs. Sukumari Koneru on 11th September, 2019.
Thi()Or ~our information and records.
vamM.a Potluri
Format for disclosures under Regulation 29(1) of SEBI (Substautial Acquisitiou of Shares and Takeovers) Regulations, 2011
Part - A - Details of the Acquisition
| Name of the Target Company eTC) | SMS Pharmaceuticals Limited | ||||||
|---|---|---|---|---|---|---|---|
| Name(s) of the acquirer and Persons Acting in | Vamsi Krishna Potluri | ||||||
| Concert (PAC) with the acquirer | |||||||
| WhetheracqUirerbelongstheto | Yes | ||||||
| Promoter/Promoter group | |||||||
| N ame( s) of the Stock Exchange( s) where the | BSE&NSE | ||||||
| shares of TC are Listed | |||||||
| Details of the acquisition as follows | Number | % w.r.t. total | 0/0 w.r.t. | ||||
| share/voting | total diluted | ||||||
| capital | share/voting | ||||||
| wherever | capital of | ||||||
| applicable | the TC (*) | ||||||
| Before the acquisitionl under consideration, | 2030590 | 2.4 | |||||
| holding of acquirer along with the P ACs of : | |||||||
| a) | Shares carrying voting rights | ||||||
| b) | Sharesof encumbrancethenaturein | ||||||
| (VR)Voting rightsotherwise thanby | |||||||
| equity shares | |||||||
| c) | Warrants/convertible securities/any other | ||||||
| instrument that entitles the acquirer to | |||||||
| receive shares carrying voting rights in theTC (specify holding in each category) | |||||||
| d) Total (a+b+c) | 2030590 | ||||||
| Details of acquisition/sale | 20,000 | 2.40.02 | |||||
| a) | Shares carrying voting rights acquired | ||||||
| b) | VRs acquired otherwise than by equity | ||||||
| shares | |||||||
| c) | Warrants/convettible securities/any other | ||||||
| instrument that entitles the acquirer to | |||||||
| receive shares carrying voting rights in the | |||||||
| TC (specify holding ineach category) | |||||||
| acquired/sold | |||||||
| d) Total (a+b+c) | 20,000 | 0.02 | |||||
| After the acquisition/sale, holding of: | 2050590 | 2.42 | |||||
| a) | Shares carrying voting rights | ||||||
| b) | VRs otherwise than by equity shares | ||||||
| c) | Warrants/convertible securities/any other | ||||||
| instrument that entitles the acquirer to | |||||||
| receive shares carrying voting rights in the | |||||||
| TC (specify holding 111each category) | |||||||
| after acquisition | . __ . |
| d) Total (a+b+c) | 2050590 | 12.42 | I | |
|---|---|---|---|---|
| Mode of acquisition/sale (e.g. open market / | Gifted to her immediate relative | |||
| off-market/publicIssue/rightsissue | ||||
| Ipreferential allotment / inter-se transfer etc.) | ||||
| Date of acquisition / sale of shares / VR or date | 18.09.2019 | |||
| of receipt of intimation of allotment of shares, | ||||
| whichever is applicable | ||||
| Equity share capital/total voting capital of the | 8,46,52,030 Equity Shares of Re 1/- | (Rupee | ||
| TC before the said acquisition/sale | one each) aggregating to Rs. 8,46,52,030 | |||
| Equity share capital! total voting capital of the | 8,46,52,030 Equity Shares of Re 1/- | (Rupee | ||
| TC after the said acquisition/sale | one each) aggregating to Rs. 8,46,52,030 | |||
| of the TCTotal diluted share/voting capital | NA | |||
| after the said acquisition/sale |
<2 Va ishna Potluri
Place: Hyderabad Date: 18.09.2019
FORM C
Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015[Regulation 7 (2) read with Regulation 6(2)]
Name of the company: SMS Pharmaceuticals Limited
ISIN of the company: INE812G01025
Details of change in holding of Securities of Promoter, Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2).
| Name,PAN No.,CIN/DIN,& addressofPromoter/Employee /Director | Categoryof Person(Promoters/ $KMP /$Directors/immediaterelatives/others | Securities heldprior toacquisition/ | disposal/Release | Securitiesaequired/Disposed/release/ | Securities held postacquisition/disposal/release (By way of gift) | Date ofallotmentadvice/acquisition ofshares/sale of sharesspecify-release ofPledge shares | Date$\circ$ fintimation tosalcompanyrights/ | Mode ofAcquisition/Dispo(marketpurchase/public | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| withcontactnos. | etc.) | Typeοfsecurity(For$eg. -$SharesWarrants,ConvertibleDebentures etc.) | No.and %ofshareholding | Type ofsecurity(For eg. $-$Shares,Warrants,ConvertibleDebentures$etc.$ ) | No. | Value | TransactionType(Buy)Sale/Pledge /Revoke/Invoke)release | Type ofsecurity(For eg.Shares,WarrantS.ConvertibleDebentures etc.) | No. and %ofshareholding | From | To | preferentialoffer / offmarket/Inter-setransferetc | |
| -1 | $\overline{2}$ | $\mathfrak{Z}$ | $4\phantom{1}$ | 5 | 6 | 7 | 8 | 9 | 10 | $\overline{11}$ | 12 | 13 | 14 |
| Vamsi KrishnaPotluriPAN:AQSPP0412FH.No: Plot No:265Q, Road No.10, Jubilee HillsHyderabad -500034 | Promoter | Equityshares | 20305902.4% | EquityShares | 20,000 | $0$ /- (receivedBy the way ofGift) | Gift | EquityShares | 20505902.42% | 11.09.2019(By way ofGiftreceived) | 11.09.2019 | 18.09.2019 | Giftreceivedfromimmediate relative |
Details of trading in derivatives of the company by Promoterl Employee or Director of a listed company and other such persons as mentioned in Regulation 6(2)
| Trading in derivatives (Specify type of contract, Futures or Options etc) | Exchange on which thetrade was executed | |||||
|---|---|---|---|---|---|---|
| Type of | Contract | Buy | Sen | |||
| Contract | Specifications | Notional Value | Number of units(contracts 'I" lotsize) | Notional Value | Number of units(contracts 'I" lotsize) | |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| Na |
m'; &;,"." '"""';
Date: 18.09.2019 Place: Hyderabad